Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Evotec sells chemical business

Evotec (FSE:EVT) agreed to sell its chemical development services business to drug development services

Read the full 146 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE